While the growing quantity of health data offers major opportunities for medical research and public health, the collection, storage and analysis of data raise numerous questions about quality, security and ownership as well as the key issues of comparability and interoperability. Against this background, the Swiss Academies of Arts and Sciences have defined personalized health as a strategic topic to be jointly addressed by the member bodies over the period 2017–2020.
The Swiss federal authorities identified the opportunities and challenges of personalized health and in 2017 launched the national funding initiative “Swiss Personalized Health Network” (SPHN) with the aim of promoting Education, Research and Innovation (ERI). The mission of the SPHN is to create an infrastructure that will connect medical data from partner institutions (hospitals with research centres, universities etc.). The SAMS assumes organizational, legal and financial responsibility for establishing the SPHN.
Do I want to know my risk of having a heart attack? Should I make my health data available to research? And who will be allowed access to this data? With questions like these, the Academies - under the auspices of Science et Cité - have invited the public to engage in a dialogue. As part of the project “The made-to-measure person: personalized health”, online questions could be answered and public dialogue events could be attended in German- or French-speaking Switzerland. The brochure “Personalized health under discussion” provides a picture of the opinions of the population group concerned.
Personalisierte Gesundheit basiert auf unzähligen personenspezifischen Daten – und betrifft früher oder später alle von uns. Bei allen Möglichkeiten, die diese Entwicklungen bieten, tauchen auch viele gesellschaftliche, juristische und ethische Fragen auf. Was hält die Bevölkerung eigentlich von diesem Wandel? Das Projekt «Mensch nach Mass» der Akademien der Wissenschaften Schweiz hat mit der Öffentlichkeit einen Dialog geführt, um herauszufinden, welche Hoffnungen und Befürchtungen die Menschen mit der personalisierten Gesundheit verbinden. In dieser Veranstaltung diskutieren wir die Ergebnisse des Projekts und werfen einen Blick in die Zukunft. Auf Fragen und Inputs aus dem Publikum sind wir sehr gespannt und verhandeln diese gerne. Es diskutieren:
Moderation: Claudia Appenzeller, exec. MPA, Generalsekretärin der Akademien der Wissenschaften Schweiz
Today, doctors can already make more precise diagnoses based on data. Personalized therapies are increasingly being developed. In the context of Covid-19, public awareness around the handling of health data has raised. But health data is sensitive and can be misused. How must the use of this data be regulated nationally and internationally in order to benefit everyone in the best way possible? We will discuss the general situation, the concept of the “Green Certificate/ Immunity Certificate” and the role of international Geneva in developing the necessary framework conditions.
This event is co-organised by the Swiss Academies and the grassroots think tank foraus, which promotes constructive foreign policy and an informed dialogue.
Introduction: Florence Balthasar, MA, Board Member of foraus
Panel:
Moderation: Claudia Appenzeller, exec. MPA, Secretary General of the Swiss Academies
Secretary General SAMS
House of Academies
Laupenstrasse 7
P.O. Box
3001 Bern
Switzerland